Essilor Stellest Lenses Slow Pediatric Myopia Progression in 7-Year Study

New data presented at the Association for Research in Vision and Ophthalmology meeting in Denver reveals that Essilor Stellest lenses significantly slowed the progression of myopia in children over a seven-year period. The findings indicate a reduction in both refractive error progression and axial length growth compared to a modeled control group.

Long-Term Efficacy in Myopia Management

The study tracked 40 children in China, representing 71% of the participants from an original two-year study. Researchers compared these children against an extrapolated single-vision lens control group based on published progression models.

After seven years, children using Essilor Stellest lenses experienced an average myopia progression of 1.53 D. In contrast, the modeled control group saw a progression of 3.83 D, representing a difference of 2.3 D.

Did You Know? Essilor Stellest is currently the only spectacle lens authorized in the United States for the slowing of pediatric myopia.

Impact on Axial Length and Adolescent Health

The research also measured axial length growth, which increased by 0.79 mm in the Essilor Stellest group. The control group experienced a larger increase of 1.71 mm, a difference of 0.92 mm.

the data showed lower rates of high myopia among adolescents up to 19 years old. Björn Drobe, PhD, director of applied myopia research at EssilorLuxottica, noted that the duration of the follow-up provides critical insight into treatment outcomes over time.

Expert Insight: Samantha Carter observes that the sustained efficacy over seven years is a significant development, as long-term clinical evidence in myopia management has historically been limited. This suggests that noninvasive spectacle lenses may provide a consistent alternative for managing pediatric vision loss in routine clinical settings.

Future Implications for Clinical practise

Because these results demonstrate continued benefit over a long period, this evidence may further support the use of these lenses in routine pediatric care. The findings could potentially strengthen the evidence base for noninvasive myopia management options.

Myopia control spectacles | Essilor® Stellest™ lenses

Future clinical applications may see an increased reliance on these lenses to maintain consistent efficacy across various populations and settings.

Frequently Asked Questions

What was the difference in myopia progression between the two groups?
Children wearing Essilor Stellest lenses had 1.53 D of progression compared to 3.83 D in the modeled control group, a difference of 2.3 D.

How did axial length growth differ in the study?
Axial length increased by 0.79 mm for those using the lenses, while the control group increased by 1.71 mm, resulting in a difference of 0.92 mm.

Who participated in this seven-year follow-up study?
The study followed 40 children in China, which included 71% of the children originally assigned to the lenses in a previous two-year study.

How do you feel about the use of specialized lenses to manage vision progression in children?